The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS

Journal of Medical Microbiology

Volumn 51, Issue 10, 2002, Pages 879-890

  Contini, Carlo ^a   Cultrera, Rosario ^a   Seraceni, Silva ^a   Segala, Daniela ^a   Romani, Roberto ^a   Fainardi, Enrico ^a   Cinque, Paola ^a   Lazzarin, Adriano ^a   Delia, Salvatore ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; ATOVAQUONE; AZITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; OLIGONUCLEOTIDE; PYRIMETHAMINE; PYRIMETHAMINE SULFADIAZINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN INJURY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENCEPHALITIS; FEMALE; GENE TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOCOMPETENCE; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; TOXOPLASMA GONDII;

EID: 0036801719     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-51-10-879     Document Type: Article

References (43)

1. Smith JE, McNeil G, Zhang YW, Dutton S, Biswas-Hughes G, Appleford P. Serological recognition of Toxoplasma gondii cyst antigens. In: Gross U (ed) Toxoplasma Gondii. (Current Topics in Microbiology and Immunology vol. 219) Berlin, Springer-Verlag. 1996: 67-73.
2. Partanen P, Turunen HJ, Paasivuo RAT, Leinikki PO. Immunoblot analysis of Toxoplasma gondii antigens by human immunogobulins G, M, and A antibodies at different stages of infection. J Clin Microbiol 1984; 20: 133-135.
3. Weiss LM, Kim K. The development and biology of bradyzoites of Toxoplasma gondii. Front Biosci 2000; 5: D391-D405.
4. Burg JL, Grover CM, Pouletty P, Boothroyd JC. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol 1989; 27: 1787-1792.
5. Nicoll S, Burns SM, Brettle RP, Leen CSL. A comparison of two methods of gene amplification for the diagnosis of Toxoplasma gondii in AIDS. J Infect 1996; 33: 177-183.
6. Cazenave J, Cheyrou A, Blouin P, Johnson AM, Begueret J. Use of polymerase chain reaction to detect Toxoplasma. J Clin Pathol 1991; 44: 1037.
7. Bohne W, Parmley SF, Young S, Gross U. In: Gross U (ed) Toxoplasma Gondii. (Current Topics in Microbiology and Immunology vol. 219) Berlin, Springer-Verlag. 1996: 81-91.
8. Franzen C, Altfeld M, Hegener P et al. Limited value of PCR for detection of Toxoplasma gondii in blood from human immunodeficiency virus-infected patients. J Clin Microbiol 1997; 35: 2639-2641.
9. Novati R, Castagna A, Morsica G et al. Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions. AIDS 1994; 8: 1691-1694.
10. Pelloux H, Dupouy-Camet, J Derouin F, Aboulker J-P, Raffi F and the Bio-Toxo Study Group. A multicentre prospective study for the polymerase chain reaction detection of Toxoplasma gondii DNA in blood samples from 186 AIDS patients with suspected toxoplasmic encephalitis. AIDS 1997; 11: 1888-1890.
11. Verhofstede C, Reniers S, Colebunders R, van Wanzeele F, Plum J. Polymerase chain reaction in the diagnosis of Toxoplasma encephalitis. AIDS 1993; 7: 1539-1541.
12. Bohne W, Gross U, Ferguson DJP, Heeseman J. Cloning and characterisation of a bradyzoite-specifically expressed gene (hsp30/bag 1) of Toxoplasma gondii related to genes encoding small heat-shock proteins of plants. Mol Microbiol 1995; 16: 1221-1230.
13. Soëte M, Dubremetz JF. Toxoplama Gondii: Kinetics of stage-specific protein expression during tachyzoite-bradyzoite conversion in vitro. In: Gross U (ed) Toxoplasma Gondii. (Current Topics in Microbiology and Immunology, vol 219) Berlin, Springer-Verlag. 1996: 75-80.
14. Parmley SF, Yang S, Harth G, Sibley D, Sucharzuk A, Remington JS. Molecular characterization of a 65-kilodaldon Toxoplasma gondii antigen expressed abundantly in the matrix of tissue cysts. Mol Biochem Parasitol 1994; 66: 283-296.
15. Lane A, Soete M, Dubremetz JF, Smith JE. Toxoplasma gondii: Appearance of specific markers during the development of tissue cysts in vitro. Parasitol Res 1996; 82: 340-346.
16. Savva D, Morris JC, Johnson JD, Holliman RE. Polymerase chain reaction for detection of Toxoplasma gondii. J Med Microbiol 1990; 32: 25-31.
17. Schoondermark van de Ven E, Galama J, Kraaijeveld C, van Druten J, Mewissen J, Melchers W. Value of polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS. Clin Infect Dis 1993; 16: 661-666.
18. Soëte M, Fortier B, Camus D, Dubremetz JF. Toxoplasma gondii: kinetics of bradyzoite-tachyzoite interconversion in vitro. Exp Parasitol 1994; 76: 259-264.
19. Kwok S, Higushi R. Avoiding false positives with PCR. Nature 1989; 339: 237-238.
20. Contini C, Seraceni S, Cultrera R. Different PCR systems to detect Toxoplasma gondii tachyzoites or bradyzoites in clinical specimens from patients with and without overt disease. J Eukaryot Microbiol 1999; 46: 77S-78S.
21. Khalifa KES, Roth A, Roth B, Arastah KN, Janischichke K. Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis. J Clin Microbiol 1994; 32: 2813-2819.
22. Odberg-Ferragut C, Soete M, Engels A et al. Molecular cloning of the Toxoplasma gondii sag-4 gene encoding an 18 kDA bradyzoite specific surface protein. Mol Biochem Parasitol 1996; 82: 237-244.
23. Cultrera R, Seraceni S, Contini C. Efficacy of a novel reverse transcriptase-polymerase chain reaction (RT-PCR) for detecting Toxoplasma gondii bradyzoite gene expression in human clinical specimens. Mol Cell Probes 2002; 16: 31-39.
24. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual Vol. 2. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press. 1989: 9.44.
25. Dembo A, Karlin S, Zeitouni O. Limit distribution of maximal non-aligned two-sequence segmental score. Ann Prob 1994; 22: 2022-2039.
26. Karlin S, Altschul SF. Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. Proc Natl Acad Sci USA 1990; 87: 2264-2268.
27. Lunde MN, Jacobs L. Antigenic differences between endozoites and cystozoites of Toxoplasma gondii. J Parasitol 1983; 69: 806-808.
28. Weiss LM, La Place D, Tanowitz HB, Wittner M. Identification of Toxoplasma gondii bradyzoite-specific monoclonal antibodies. J Infect Dis 1992; 166: 213-215.
29. Ammassarri A, Murri R, Cingolani A, De Luca A, Antinori A. AIDS-associated cerebral toxoplamosis: An update on diagnosis and treatment. In: Gross U (ed) Toxoplasma Gondii. (Current Topics in Microbiology and Immunology vol. 219) Berlin, Springer-Verlag. 1996: 209-222.
30. Cristina N, Liaud M-F, Santoro F, Oury B, Ambrose-Thomas P. A family of repeated DNA sequences in Toxoplasma gondii: Cloning, sequence analysis, and use in strain characterization. Exp Parasitol 1991; 73: 73-81.
31. Roth A, Roth B, Hoffken G, Steuber S, Khalifa KI, Janitschke K. Application of polymerase chain reaction in the diagnosis of pulmonary toxoplasmosis in immunocompromised patients. Eur J Clin Microbiol Infect Dis 1992; 11: 1177-1181.
32. Khoury H, Adkins D, Brown R et al. Successful treatment of cerebral toxoplasmosis in a marrow transplant recipient: Contribution of a PCR test in diagnosis and early detection. Bone Marrow Transplant 1999; 23: 409-411.
33. Lamoril J, Molina JM, de Gouvello A et al. Detection by PCR of Toxoplasma gondii in blood in the diagnosis of cerebral toxoplasmosis in patients with AIDS. J Clin Pathol 1996; 49: 89-92.
34. Cingolani A, De Luca A, Ammassari A et al. Detection of T. gondii-DNA by PCR in AIDS-related toxoplasmic encephalitis. J Eukaryot Microbiol 1996; 43: 118S-119S.
35. Odaert H, Soëte M, Fortier B, Camus D, Dubremetz JF. Stage conversion of Toxoplasma gondii in mouse brain during infection and immunodepression. Parasitol Res 1996; 82: 28-31.
36. Gross U, Bohne W, Soëte M, Dubremetz JF. Developmental differentiation between tachyzoites and bradyzoites of Toxoplasma gondii. Parasitol Today 1996; 12: 30-33.
37. Gross U, Bohne W, Luder CGK et al. Regulation of developmental differentiation in the protozoan parasite Toxoplasma gondii. J Eukaryot Microbiol 1996; 43: 114S-116S.
38. Eggers C, Gross U, Klinker H, Schalke B, Stellbrink HJ, Kunze K. Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS. J Neurol 1995; 242: 644-649.
39. Dupoy-Camet J, Lavareda de Souza S et al. Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction. J Clin Microbiol 1993; 31: 1866-1869.
40. Foudrinier F, Aubert D, Puygauthier-Tobas D et al. Detection of Toxoplasma gondii in immunodeficient subjects by gene amplification: Influence of therapeutics. Scand J Infect Dis 1996; 28: 383-386.
41. Araujo FG, Huskinson J, Remington JS. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrob Agents Chemother 1991; 35: 293-299.
42. Gross U, Pohl F. Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii. In: Gross U (ed) Toxoplasma Gondii. (Current Topics in Microbiology and Immunology, vol. 219) Berlin, Springer-Verlag. 1996: 235-245.
43. Pomeroy C, Kline S, Jordan MC, Filice GA. Reactivation of Toxoplasma gondii by cytomegalovirus disease in mice: Antimicrobial activity of macrophages. J Infect Dis 1989; 160: 305-311.